Altium Capital Management LP Essa Pharma Inc. Transaction History

Altium Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$6.18 - $14.44 $2.13 Million - $4.98 Million	-345,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$7.8 - $14.38 $2.69 Million - $4.96 Million	345,000 New	345,000 $4.9 Million
Q3 2021 Nov 15, 2021	SELL	$7.76 - $29.37 $1.66 Million - $6.27 Million	-213,528 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$24.17 - $34.28 $399,650 - $566,819	-16,535 Reduced 7.19%	213,528 $6.1 Million
Q1 2021 May 06, 2021	BUY	$11.61 - $32.08 $638,503 - $1.76 Million	54,996 Added 31.41%	230,063 $6.68 Million
Q4 2020 Feb 16, 2021	BUY	$5.47 - $12.1 $957,616 - $2.12 Million	175,067 New	175,067 $2.09 Million

35.1M

15.8K

21K

Ticker EPIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,073,100
Market Cap $72.3M
Description
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...

Get notified when there are updates to the investment portfolio of Altium Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Altium Capital Management LP with notifications on news.